Authors:
LANKEN PN
TERRY PB
ADLER DC
BROOKSBRUNN JA
CRAWFORD SW
DANIS M
FEDULLO AJ
GOTTLIEB JE
HANSENFLASCHEN J
KOLLEF MH
LEMAIRE F
LUCE JB
OSBORNE ML
PAZ HL
POPOVITCH J
RAFFIN TA
RICE CL
ROGERS TR
ROSEN MJ
RUBENFELD GD
SHELHAMER JH
SIBBALD WJ
SNIDER GL
STAUFFER JL
TRUOG RD
VINCENT JE
WILFOND BS
ANNAS GJ
ARRAS JD
ASCH DA
CAPLAN AL
Citation: Pn. Lanken et al., FAIR ALLOCATION OF INTENSIVE-CARE UNIT RESOURCES (VOL 156, PG 1282, 1997), American journal of respiratory and critical care medicine, 157(2), 1998, pp. 671-671
Authors:
BURKE W
THOMSON E
KHOURY MJ
MCDONNELL SM
PRESS N
ADAMS PC
BARTON JC
BEUTLER E
BRITTENHAM G
BUCHANAN A
CLAYTON EW
COGSWELL ME
MESLIN EM
MOTULSKY AG
POWELL LW
SIGAL E
WILFOND BS
COLLINS FS
Citation: W. Burke et al., HEREDITARY HEMOCHROMATOSIS - GENE DISCOVERY AND ITS IMPLICATIONS FOR POPULATION-BASED SCREENING, JAMA, the journal of the American Medical Association, 280(2), 1998, pp. 172-178
Authors:
MISCHLER EH
WILFOND BS
FOST N
LAXOVA A
REISER C
SAUER CM
MAKHOLM LM
SHEN GH
FEENAN L
MCCARTHY C
FARRELL PM
Citation: Eh. Mischler et al., CYSTIC-FIBROSIS NEWBORN SCREENING - IMPACT ON REPRODUCTIVE-BEHAVIOR AND IMPLICATIONS FOR GENETIC-COUNSELING, Pediatrics (Evanston), 102(1), 1998, pp. 44-52
Citation: Gl. Loeben et al., MIXED MESSAGES - PRESENTATION OF INFORMATION IN CYSTIC-FIBROSIS SCREENING PAMPHLETS, American journal of human genetics, 63(4), 1998, pp. 1181-1189
Authors:
LANKEN PN
TERRY PB
ADLER DC
BROOKSBRUNN JA
CRAWFORD SW
DANIS M
FEDULLO AJ
GOTTLIEB JE
HANSENFLASCHEN J
KOLLEF MH
LEMAIRE F
LUCE JM
OSBORNE ML
PAZ HL
POPOVITCH J
RAFFIN TA
RICE CL
ROGERS TR
ROSEN MJ
RUBENFELD GD
SHELHAMER JH
SIBBALD WJ
SNIDER GL
STAUFFER JL
TRUOG RD
VINCENT JE
WILFOND BS
ANNAS GJ
ARRAS JD
ASCH DA
CAPLAN AL
Citation: Pn. Lanken et al., FAIR ALLOCATION OF INTENSIVE-CARE UNIT RESOURCES, American journal of respiratory and critical care medicine, 156(4), 1997, pp. 1282-1301
Authors:
WILFOND BS
ROTHENBERG KH
THOMSON EJ
LERMAN C
Citation: Bs. Wilfond et al., CANCER GENETIC SUSCEPTIBILITY TESTING - ETHICAL AND POLICY IMPLICATIONS FOR FUTURE-RESEARCH AND CLINICAL-PRACTICE, The Journal of law, medicine & ethics, 25(4), 1997, pp. 243
Authors:
SUGARMAN J
KAALUND V
KODISH E
MARSHALL MF
REISNER EG
WILFOND BS
WOLPE PR
HAGE ML
KURTZBERG J
OLSON J
CAPRON AM
FADEN RR
POWERS M
HARVATH L
HOWE CWS
Citation: J. Sugarman et al., ETHICAL ISSUES IN UMBILICAL-CORD BLOOD BANKING, JAMA, the journal of the American Medical Association, 278(11), 1997, pp. 938-943
Citation: Bs. Wilfond et D. Baker, GENETIC-COUNSELING, NON-DIRECTIVENESS, AND CLIENTS VALUES - IS WHAT CLIENTS SAY, WHAT THEY MEAN, The Journal of clinical ethics, 6(2), 1995, pp. 180-182
Authors:
WILFOND BS
PELIAS MZ
KNOPPERS BM
REILLY PR
WERTZ DC
BILLINGS P
FLEISHER LD
ROWLEY P
STROM C
ZINBERG R
BOYD P
CLAYTON EW
FANOS J
MARKEL D
SCHNEIDER K
Citation: Bs. Wilfond et al., POINTS TO CONSIDER - ETHICAL, LEGAL, AND PSYCHOSOCIAL IMPLICATIONS OFGENETIC TESTING IN CHILDREN AND ADOLESCENTS, American journal of human genetics, 57(5), 1995, pp. 1233-1241
Citation: Bs. Wilfond et K. Nolan, DEVELOPING THE CLINICAL-APPLICATION OF GENETIC DIAGNOSIS - THE ROLE OF NIDDK - REPLY, JAMA, the journal of the American Medical Association, 271(16), 1994, pp. 1240-1240
Authors:
WILFOND BS
FARRELL PM
LAXOVA A
MISCHLER E
Citation: Bs. Wilfond et al., SEVERE HEMOLYTIC-ANEMIA ASSOCIATED WITH VITAMIN-E-DEFICIENCY IN INFANTS WITH CYSTIC-FIBROSIS - IMPLICATIONS FOR NEONATAL SCREENING, Clinical pediatrics, 33(1), 1994, pp. 2-7
Citation: Bs. Wilfond et K. Nolan, NATIONAL POLICY DEVELOPMENT FOR THE CLINICAL-APPLICATION OF GENETIC DIAGNOSTIC TECHNOLOGIES - LESSONS FROM CYSTIC-FIBROSIS, JAMA, the journal of the American Medical Association, 270(24), 1993, pp. 2948-2954